Online citations, reference lists, and bibliographies.
← Back to Search

Controlled Drug Release And Cytotoxicity Studies Of Beta-Lapachone And Doxorubicin Loaded Into Cyclodextrins Attached To A Polyethyleneimine Matrix

A. Kowalczyk, A. Kasprzak, M. Popławska, Monika Rużycka, I. Grudzinski, A. Nowicka
Published 2020 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This work presents a new look at the application of cyclodextrins (CD) as a drug nanocarrier. Two different cyclodextrins (αCD, βCD) were covalently conjugated to branched polyethylenimine (PEI), which was additionally functionalized with folic acid (PEI-βCD-αCD-FA). Here, we demonstrated that the combination of αCD and βCD enabled to load and control release of two anticancer drugs: doxorubicin (DOX) and beta-lapachone (beta-LP) (DOX in β-CD and beta-LP into α-CD) via host-guest inclusion. The PEI-βCD(DOX)-αCD-FA nanoconjugate was used to transport anticancer drugs into A549 lung cancer cells for estimation the cytotoxic and antitumor effect of this nanoconjugate. The presence of FA molecules should facilitate the penetration of studied nanoconjugate into the cell. Whereas, the non-cellular experiments proved that the drugs are released from the carrier mainly in the pH 4.0. The release mechanism is found to be anomalous in all studied cases.
This paper references
10.1310/hpj5106-442
Carboplatin and Liposomal Doxorubicin for Ovarian Cancer
J. Nguyen (2016)
10.1021/nn900918w
Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs.
T. Xia (2009)
10.14670/HH-13.89
beta-Lapachone induced cell death in human hepatoma (HepA2) cells.
C. Lai (1998)
10.1074/JBC.M402305200
Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-κB-dependent XIAP Up-Regulation*
M. Lin (2004)
10.1016/J.EURPOLYMJ.2012.07.009
Polypeptide-based star-block quadripolymers as unimolecular nanocarriers for the simultaneous encapsulation of hydrophobic and hydrophilic guests
J. Li (2012)
Effects of docetaxel, doxorubicin and cyclophosphamide on human breast cancer cell line MCF-7.
Marianna Trebuňová (2012)
10.1097/FPC.0b013e32833ffb56
Doxorubicin pathways: pharmacodynamics and adverse effects
C. Thorn (2011)
10.1345/APH.1G685
Book Review: Goodman and Gilman's The Pharmacological Basis of Therapeutics: Digital Edition, 11th Edition
L. Brunton (2006)
beta-lapachone induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2 family and activation of caspases.
J. I. Lee (2006)
10.1007/s13233-015-3047-8
Improved biocompatibility of polyethylenimine (PEI) as a gene carrier by conjugating urocanic acid: In vitro and in vivo
Jong Eun Ihm (2015)
10.1124/MOL.59.4.784
Induction of CDK inhibitors (p21(WAF1) and p27(Kip1)) and Bak in the beta-lapachone-induced apoptosis of human prostate cancer cells.
M. Don (2001)
ffi cacy of beta - lapachone in pancreatic cancer treatment : Exploiting the novel , therapeutic target NQO 1
M. Ough (2005)
10.1586/17474124.2.5.673
New treatment options for advanced pancreatic cancer
G. Middleton (2008)
10.1111/jcpt.13039
Application of capsaicin as a potential new therapeutic drug in human cancers
Shengping Zhang (2019)
10.1080/10717544.2017.1391889
Transporting carriers for intracellular targeting delivery via non-endocytic uptake pathways
Z. Li (2017)
Review skeletal drug delivery systems
A. K. Jain (2000)
10.1039/C6TB02620F
A multifunctional polyethylenimine-based nanoplatform for targeted anticancer drug delivery to tumors in vivo.
B. Zhou (2017)
10.3322/caac.21492
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
F. Bray (2018)
10.1155/2015/198268
A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs
B. Gidwani (2015)
10.1016/j.addr.2018.07.007
Tumor targeting via EPR: Strategies to enhance patient responses.
Susanne K Golombek (2018)
10.1158/1078-0432.CCR-10-1983
Modulating Endogenous NQO1 Levels Identifies Key Regulatory Mechanisms of Action of β-Lapachone for Pancreatic Cancer Therapy
L. Li (2011)
10.2147/DDDT.S92273
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles
C. Melguizo (2015)
10.1155/2013/456409
Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review
J. Lao (2013)
10.1002/JPS.20457
Folate receptor-mediated drug targeting: from therapeutics to diagnostics.
A. Hilgenbrink (2005)
10.1002/14651858.CD010482.pub2
Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancer.
T. Lawrie (2013)
10.1002/cmdc.200700159
Prodrug Strategies in Anticancer Chemotherapy
F. Kratz (2008)
10.1155/2013/898146
Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian Cancer
C. Pisano (2013)
10.1023/A:1026143519395
Enhancement of Solubility and Bioavailability of β-Lapachone Using Cyclodextrin Inclusion Complexes
N. Nasongkla (2004)
Inhibition of poly(ADP-ribose) polymerase activation attenuates beta-lapachone-induced necrotic cell death in human osteosarcoma cells.
Tcho-Jen Liu (2002)
10.1006/TAAP.2002.9438
Inhibition of Poly(ADP-ribose) Polymerase Activation Attenuates β-Lapachone-Induced Necrotic Cell Death in Human Osteosarcoma Cells
Tcho-Jen Liu (2002)
10.1016/j.clgc.2019.09.005
Effectiveness of Intravesical Doxorubicin Immediately Following Resection of Primary Non-muscle-invasive Bladder Cancer: A Propensity Score-matched Analysis.
Wataru Fukuokaya (2019)
Synthesis and evaluation of some newer pyrazolines as possible potential antitumor agents
K. Divekar (2020)
10.1073/pnas.0702176104
An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone
E. Bey (2007)
10.1074/jbc.M117.813923
The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism
Molly A Silvers (2017)
10.1021/mp300293n
Endocytosis and intracellular trafficking as gateways for nanomedicine delivery: opportunities and challenges.
R. Duncan (2012)
Zeta potential in colloid science : principles and applications
R. Hunter (1981)
10.1021/ol403776k
13C NMR Spectroscopy for the Quantitative Determination of Compound Ratios and Polymer End Groups
Douglas A. L. Otte (2014)
Activation of c-Jun NH2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor beta-lapachone-induced apoptosis through an oxidation-dependent pathway.
S. Shiah (1999)
10.1016/j.biopha.2019.108614
Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
Y. Hong (2019)
10.1002/mabi.201700289
New Insight into the Synthesis and Biological Activity of the Polymeric Materials Consisting of Folic Acid and β-Cyclodextrin.
A. Kasprzak (2018)
10.1002/POLA.21526
Core–shell‐type multiarm star polyethylenimine‐block‐poly(ε‐caprolactone): Synthesis and guest encapsulation potential
Huaji Liu (2006)
10.1186/s12885-017-3953-6
Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins
C. Lovitt (2017)
ff ects of docetaxel , doxorubicin and cyclophosphamide on human breast cancer cell line MCF - 7
T. A. Lawrie (2012)
10.1016/S0928-0987(01)00095-1
Modeling and comparison of dissolution profiles.
P. Costa (2001)
10.1016/J.EURPOLYMJ.2008.01.035
Core-shell type multiarm star poly(ε-caprolactone) with high molecular weight hyperbranched polyethylenimine as core: Synthesis, characterization and encapsulation properties
X. Cao (2008)
10.1038/s41598-019-39107-3
Polymeric Engineering of Nanoparticles for Highly Efficient Multifunctional Drug Delivery Systems
B. Fortuni (2019)
10.1038/s41467-020-14367-0
Pathway and network analysis of more than 2500 whole cancer genomes
Matthew A. Reyna (2020)
ff ectiveness of Intravesical Doxorubicin Immediately Following Resection of Primary Non – muscle - invasive Bladder Cancer : A Propensity Score - matched Analysis
Y. Hong
10.1016/j.biomaterials.2017.05.034
Revisiting the value of competition assays in folate receptor-mediated drug delivery.
S. Jones (2017)
10.1016/J.JMR.2006.01.015
Improvement of the inverse-gated-decoupling sequence for a faster quantitative analysis of various samples by 13C NMR spectroscopy.
P. Giraudeau (2006)
10.1021/ACS.BIOCONJCHEM.6B00437
Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?
Y. Nakamura (2016)
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license
10.1038/s41467-020-14310-3
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
Alessandro Leal (2020)
10.1016/j.ejmech.2020.112181
Synthesis and structure-activity relationship study of water-soluble carbazole sulfonamide derivatives as new anticancer agents.
Yong-Hua Liu (2020)
10.1016/S0378-5173(00)00468-3
Skeletal drug delivery systems.
A. Jain (2000)
10.4161/cbt.4.1.1382
Efficacy of beta-lapachone in pancreatic cancer treatment: Exploiting the novel, therapeutic target NQO1
Matthew Ough (2005)
10.1080/20022727.2018.1488497
Polyethylenimine-based nanocarriers in co-delivery of drug and gene: a developing horizon
A. Zakeri (2018)
Acid pH in tumors and its potential for therapeutic exploitation.
I. Tannock (1989)
10.1016/0022-1759(94)90396-4
A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay.
S. A. Ahmed (1994)
10.1186/1475-2867-13-89
Acidic extracellular microenvironment and cancer
Y. Kato (2013)
10.3402/nano.v3i0.18496
Utilizing the folate receptor for active targeting of cancer nanotherapeutics
Grant L. Zwicke (2012)
10.1038/s41598-020-59031-1
Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression
Yen-Shou Kuo (2020)
10.1016/S0891-5849(97)00337-7
Involvement of hydrogen peroxide in topoisomerase inhibitor beta-lapachone-induced apoptosis and differentiation in human leukemia cells.
Y. P. Chau (1998)
10.1016/0731-7085(90)80100-4
Inclusion complexation of doxorubicin and daunorubicin with cyclodextrins.
O. Bekers (1990)
10.3390/biom10010158
Anti-Migratory and Pro-Apoptotic Properties of Parvifloron D on Triple-Negative Breast Cancer Cells
N. Saraiva (2020)



Semantic Scholar Logo Some data provided by SemanticScholar